← All indications
Birth Weight
The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
Subtype terms (1)
More specific conditions that are subtypes of Birth Weight in the MeSH hierarchy.
- Fetal Macrosomia
4 drugs approved
Drugs by status
Phase 2 trials (1)
Organizations
Organization Involved with Phase 4 Indications (38)
- Cumberland Pharmaceuticals
- Bandim Health Project
- Jhpiego
- National Heart, Lung, and Blood Institute (NHLBI)
- Aarhus University
- Harvard University
- Hopital La Rabta
- Johns Hopkins University
- KK Women's and Children's Hospital
- Oregon Health and Science University
- Pontificia Universidad Catolica de Chile
- Sir Takhtasinhji General Hospital
- University of Siena
- University of South Florida
- University of California, Davis
- University of Cincinnati
- University of Vienna
- Leiden University
- Umea University
- University of Indonesia
- Medical University of Vienna
- National University of Singapore
- Zekai Tahir Burak Hospital
- Canterbury District Health Board
- Medical Research Council, The Gambia
- University of Otago
- The Swedish Research Council
- Bill and Melinda Gates Foundation
- International Food Policy Research Institute
- March of Dimes
- +8 more
Organization Involved with Phase 3 Indications (60)
- Biosynexus Incorporated
- DSM
- Vermont Oxford Network
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- University of Pennsylvania
- Brown University
- Case Western Reserve University
- Chulalongkorn University
- Cornell University
- Duke University
- Emory University
- Indian Council of Medical Research
- Indiana University
- Mahidol University
- McMaster University
- Medical College of Wisconsin
- Northwestern University
- Ohio State University
- RTI International
- Stanford University
- Tufts University
- University of Florida
- University of Iowa
- University of Kansas
- University of Miami
- University of New Mexico
- University of Rochester
- University of Sydney
- University of Tennessee
- +30 more
Organization Involved with Phase 2 Indications (19)
- Pfizer
- BioGaia AB
- Nabi Biopharmaceuticals
- Windtree Therapeutics
- National Eye Institute (NEI)
- Ajou University
- University of Washington
- Korea University
- Ostergotland County Council, Sweden
- Seoul National University
- University of Oulu
- Yonsei University
- Laval University
- University of North Carolina at Chapel Hill
- Linkoping University
- The Ekhaga Foundation, Stockholm, Sweden
- China Medical University
- Medical Research Council, Sweden
- Centers for Disease Control and Prevention (CDC)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (49)
- Roche
- Mallinckrodt
- Prolacta Bioscience
- World Health Organization
- Region Syddanmark
- University of London
- Delhi University
- Gottfried Wilhelm Leibniz Universität Hannover
- King Faisal University
- Northwell Health
- Rockford Memorial Hospital
- RWTH Aachen University
- Sitaram Bhartia Institute of Science and Research
- Tokyo Women's Medical University
- University of Oklahoma
- University of Pavia
- University of South Carolina
- University of Southern Denmark
- University of Alberta
- University of Valencia
- University of Zurich
- Assiut University
- Taipei Medical University
- University of Calgary
- University of Cologne
- University of Copenhagen
- Université catholique de Louvain
- University of Ulm
- Medical University of South Carolina
- All India Institute of Medical Sciences
- +19 more